Clinical Trial Update: Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure [NA]

View source ↗

Summary

Clinical trial update on pulpotomy in permanent teeth with caries exposure using MTA and Biodentine; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Drugs mentioned

• Biodentine (tricalcium silicate cement)
• MTA (Mineral Trioxide Aggregate) (mineral trioxide aggregate)

Snippet

Sponsor: Altamash Institute of Dental Medicine | Conditions: Pulpitis - Irreversible | NA | Status: NOT_YET_RECRUITING